Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. (Photo by Eric Thayer/Getty Images) Getty Images

Two weeks ago, President Trump sent letters to 17 leading pharmaceutical manufacturers, giving them 60 days to propose plans to lower U.S. drug prices to align with the lowest prices offered in other developed nations.

This is an opportunity to recalibrate pharmaceutical pricing in a way that brings relief to U.S. consumers, corrects global imbalances and safeguards innovation, a transition the entire healthcare ecosystem must eventually adopt.

Most discussions about drug prices focus narrowly on the retail cost patients see at the pharmacy counter, but these are only a fraction of the real economic picture.

Trump’s directive aims to address a

See Full Page